Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2021-11-01 Declaration of Voting R…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the RNS Number (9601Q) and explicitly mentions 'RNS Number' and 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider'. The content details the 'Total Voting Rights' as of a specific date (31 October 2021) and provides the denominator figure for shareholder notifications under the UK FCA's Disclosure and Transparency Rules. This type of mandatory, short-form regulatory update, which is not a comprehensive report (like 10-K or IR) and does not fit other specific categories (like DIRS or DIV), falls best under the general regulatory announcement category, RNS.
2021-11-01 English
Q3 Trading Update
Earnings Release Classification · 1% confidence The document is identified by the RNS Number (6483Q) and the header 'RNS Number'. It provides a 'Trading update for the three months ended 30 September 2021' (Q3 performance), including key financial metrics, strategic progress, and updated full-year guidance. This content structure—a brief update on recent performance with forward-looking guidance—is characteristic of an Earnings Release (ER). Although it contains detailed tables, its primary function is the initial announcement of period results, not the comprehensive filing like a 10-K or IR. The presence of the RNS distribution footer confirms it is a regulatory news service announcement. Q3 2021
2021-10-29 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a notification regarding 'Director/PDMR Shareholding' transactions for two executives (Frank Schulkes and Rick Anderson). This type of filing, detailing personal share transactions by company directors and executives, directly matches the definition for Director's Dealing. The presence of the RNS distribution information and the structure strongly suggest a regulatory announcement, but the specific content points to DIRS over the general RNS fallback. It is not a full financial report (10-K, IR) or a general announcement of a report (RPA).
2021-10-18 English
Pricing of $500M 3.875% Senior Notes due 2029
Capital/Financing Update Classification · 1% confidence The document is identified by the header 'RNS Number' and contains details about a specific financial transaction: the pricing of a $500 Million Senior Notes offering. This announcement details the terms of debt issuance and the intended use of proceeds (prepaying borrowings under a Credit Facility Agreement). This activity falls directly under the definition of 'Capital/Financing Update' (CAP). Although it is distributed via RNS, the core content is a financing announcement, making CAP the most specific classification. It is not a general regulatory filing (RNS) because the subject matter is highly specific to capital structure changes.
2021-10-01 English
ConvaTec Announces Offer of $500M Senior Notes
Capital/Financing Update Classification · 1% confidence The document is identified by the header 'RNS Number : 5886N' and contains an announcement titled 'ConvaTec Group Plc Announces Offering of $500 Million Senior Notes due 2029'. This clearly indicates a corporate action related to financing, specifically the issuance of debt securities (senior notes). This falls directly under the definition of 'Capital/Financing Update' (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP the most specific and appropriate classification over the general RNS fallback.
2021-09-30 English
Scrip Dividend - Total Issued Shares
Notice of Dividend Amount Classification · 1% confidence The document is identified by the RNS Number header and contains specific details about a dividend payment, including the declaration of an interim dividend, the option for a scrip dividend alternative, the number of new shares to be issued (750,265), and the resulting total issued share capital. This content directly relates to the announcement of a dividend amount and associated share issuance details. This aligns perfectly with the 'Notice of Dividend Amount' (DIV) definition. Although it involves share issuance, the primary focus and context are the dividend mechanics, making DIV more specific than SHA or CAP. It is not a general regulatory filing (RNS) because it fits a specific category.
2021-09-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.